| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/TP.2015.211 |
| P8608 | Fatcat ID | release_hsj64b3mprhnfmla62uomq4dci |
| P932 | PMC publication ID | 4872419 |
| P698 | PubMed publication ID | 26836412 |
| P5875 | ResearchGate publication ID | 292947486 |
| P50 | author | Vince D. Calhoun | Q24924339 |
| Jessica A. Turner | Q30514179 | ||
| Stefan Ehrlich | Q42670586 | ||
| P2093 | author name string | L Wang | |
| J Chen | |||
| V Patel | |||
| C Wright | |||
| N I Perrone-Bizzozero | |||
| C N Gupta | |||
| J R Bustillo | |||
| P2860 | cites work | miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 |
| Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 | ||
| Identification of mammalian microRNA host genes and transcription units | Q24562298 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies | Q24626182 | ||
| MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1 | Q24630616 | ||
| The schizophrenia risk gene product miR-137 alters presynaptic plasticity. | Q27312392 | ||
| Genome-wide association study identifies five new schizophrenia loci | Q28248384 | ||
| Common polygenic variation contributes to risk of schizophrenia and bipolar disorder | Q28250609 | ||
| Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment | Q28285951 | ||
| Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing | Q28294203 | ||
| Genome-wide association analysis identifies 13 new risk loci for schizophrenia | Q28297287 | ||
| Northwestern University Schizophrenia Data and Software Tool (NUSDAST) | Q28661735 | ||
| G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences | Q29547562 | ||
| Unified segmentation | Q29616050 | ||
| When Broca goes uninformed: reduced information flow to Broca's area in schizophrenia patients with auditory hallucinations | Q30432113 | ||
| Frontal and superior temporal auditory processing abnormalities in schizophrenia | Q30447895 | ||
| Potential Impact of miR-137 and Its Targets in Schizophrenia | Q30454963 | ||
| Somatosensory system deficits in schizophrenia revealed by MEG during a median-nerve oddball task | Q30483353 | ||
| The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia | Q30646868 | ||
| PKA, Rap1, ERK1/2, and p90RSK mediate PGE2 and EP4 signaling in neonatal ventricular myocytes | Q33589237 | ||
| Converging on a core cognitive deficit: the impact of various neurodevelopmental insults on cognitive control | Q33736819 | ||
| Cross talk between microRNA and epigenetic regulation in adult neurogenesis | Q33788417 | ||
| Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia | Q33872654 | ||
| The impact of MIR137 on dorsolateral prefrontal-hippocampal functional connectivity in healthy subjects | Q33923604 | ||
| Exploration of scanning effects in multi-site structural MRI studies | Q33965706 | ||
| Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome | Q33989539 | ||
| Neuroanatomical circuitry associated with exploratory eye movement in schizophrenia: a voxel-based morphometric study | Q34047121 | ||
| Prefrontal inefficiency is associated with polygenic risk for schizophrenia | Q34322910 | ||
| Resting state functional connectivity in patients with chronic hallucinations. | Q34412071 | ||
| Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis | Q34458640 | ||
| No effect of schizophrenia risk genes MIR137, TCF4, and ZNF804A on macroscopic brain structure | Q34578760 | ||
| Mapping cortical morphology in youth with velocardiofacial (22q11.2 deletion) syndrome | Q34806546 | ||
| Genetic markers of white matter integrity in schizophrenia revealed by parallel ICA. | Q35140785 | ||
| Meta gene set enrichment analyses link miR-137-regulated pathways with schizophrenia risk | Q35489742 | ||
| Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation | Q35596962 | ||
| Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia | Q35760215 | ||
| The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia | Q48140110 | ||
| Patterned vision causes CRE-mediated gene expression in the visual cortex through PKA and ERK. | Q48232747 | ||
| Key functional circuitry altered in schizophrenia involves parietal regions associated with sense of self | Q48364325 | ||
| Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging. | Q49046364 | ||
| Modeling neuropsychiatric spectra to empower translational biological psychiatry. | Q50660868 | ||
| Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. | Q51777217 | ||
| Modeling by shortest data description | Q55966897 | ||
| miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells | Q35818683 | ||
| Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells. | Q35890950 | ||
| MIR137HG risk variant rs1625579 genotype is related to corpus callosum volume in schizophrenia | Q35940904 | ||
| Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis | Q35950776 | ||
| Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia | Q35992194 | ||
| Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals | Q36245041 | ||
| Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder | Q36323567 | ||
| Adult neurogenesis and schizophrenia: a window on abnormal early brain development? | Q36661948 | ||
| Cumulative genetic risk and prefrontal activity in patients with schizophrenia | Q36770072 | ||
| Grey matter and cognitive deficits in young relatives of schizophrenia patients | Q36948723 | ||
| Heritability of multivariate gray matter measures in schizophrenia | Q36960391 | ||
| Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex | Q37120426 | ||
| Guided exploration of genomic risk for gray matter abnormalities in schizophrenia using parallel independent component analysis with reference | Q37231051 | ||
| Source-based morphometry: the use of independent component analysis to identify gray matter differences with application to schizophrenia | Q37362275 | ||
| Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells | Q37706529 | ||
| Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective. | Q38177652 | ||
| Transcriptional targets of the schizophrenia risk gene MIR137. | Q38979078 | ||
| MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. | Q39234754 | ||
| miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. | Q39239384 | ||
| miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2. | Q39382240 | ||
| miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. | Q39609457 | ||
| Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination | Q40366558 | ||
| The impact of genome wide supported microRNA-137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia. | Q41002359 | ||
| Conflict and error processing in an extended cingulo-opercular and cerebellar network in schizophrenia | Q42029558 | ||
| Genome-wide schizophrenia variant at MIR137 does not impact white matter microstructure in healthy participants | Q43515220 | ||
| Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2. | Q44055176 | ||
| Effects of a CACNA1C genotype on attention networks in healthy individuals | Q44490894 | ||
| Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets | Q45263643 | ||
| Effects of MIR137 on fronto-amygdala functional connectivity | Q46690026 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | microRNA | Q310899 |
| schizophrenia | Q41112 | ||
| P304 | page(s) | e724 | |
| P577 | publication date | 2016-02-02 | |
| P1433 | published in | Translational Psychiatry | Q15716636 |
| P1476 | title | Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia | |
| P478 | volume | 6 |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q39031282 | Associations of microRNA single nucleotide polymorphisms and disease risk and pathophysiology |
| Q94671562 | Cortical cellular diversity and development in schizophrenia |
| Q39298012 | Emerging role of miRNA in attention deficit hyperactivity disorder: a systematic review |
| Q39143511 | Genomic Editing of Non-Coding RNA Genes with CRISPR/Cas9 Ushers in a Potential Novel Approach to Study and Treat Schizophrenia |
| Q91906469 | Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer |
| Q47870167 | Mapping the Schizophrenia Genes by Neuroimaging: The Opportunities and the Challenges |
| Q39002120 | MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls |
| Q39414160 | MicroRNAs in neural development: from master regulators to fine-tuners |
| Q38622665 | Multimodal Neuroimaging in Schizophrenia: Description and Dissemination. |
| Q90114172 | Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development |
| Q52320951 | Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia. |
| Q94517766 | TS: a powerful truncated test to detect novel disease associated genes using publicly available gWAS summary data |
| Q37740639 | The Emerging Role of Epigenetics in Autoimmune Thyroid Diseases. |
| Q90409942 | Variants of MIR137HG Genes are Associated with Liver Cancer Risk in Chinese Li Population |
| Q89684847 | [Association of microRNA expression before and after drug therapy with clinical symptoms in children with attention deficit hyperactivity disorder] |
| Q60958314 | microRNAs Sculpt Neuronal Communication in a Tight Balance That Is Lost in Neurological Disease |
Search more.